Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Laser therapy for vulvo-vaginal atrophy / genito-urinary syndrome of menopause in breast cancer survivors

Prof Deborah Fenlon - Swansea University, Swansea, UK
Laser therapy for vulvo-vaginal atrophy / genito-urinary syndrome of menopause in breast cancer survivors ( Prof Deborah Fenlon - Swansea University, Swansea, UK )
12 Dec 2019

Precision medicine treatment in older AML: Results of Beat AML master trial

Dr Amy Burd - Leukemia and Lymphoma Society, White Plains, USA
Precision medicine treatment in older AML: Results of Beat AML master trial ( Dr Amy Burd - Leukemia and Lymphoma Society, White Plains, USA )
10 Dec 2019

Older patients with non-Hodgkin lymphoma can be treated successfully with CAR T-cell therapy

Dr Karl Kilgore - Avalere Health, Bowie, USA
Older patients with non-Hodgkin lymphoma can be treated successfully with CAR T-cell therapy ( Dr Karl Kilgore - Avalere Health, Bowie, USA )
10 Dec 2019

CARTITIUDE-1: BCMA-targeted CAR T-cell therapy shows high response rates in patients with multiple myeloma

Prof Deepu Madduri - Mount Sinai, New York, USA
CARTITIUDE-1: BCMA-targeted CAR T-cell therapy shows high response rates in patients with multiple myeloma ( Prof Deepu Madduri - Mount Sinai, New York, USA )
10 Dec 2019

Blinatumomab vs chemotherapy as post-reinduction therapy in HR/IR first relapse of B-ALL in children and adolescents

Dr Patrick Brown - Johns Hopkins University, Baltimore, USA
Blinatumomab vs chemotherapy as post-reinduction therapy in HR/IR first relapse of B-ALL in children and adolescents ( Dr Patrick Brown - Johns Hopkins University, Baltimore, USA )
10 Dec 2019

Identifying prognostic constellations of driver mutations in acute myeloid leukaemia and myelodysplastic syndromes

Dr Charles Mullighan - St. Jude Children's Research Hospital, Memphis, USA
Identifying prognostic constellations of driver mutations in acute myeloid leukaemia and myelodysplastic syndromes ( Dr Charles Mullighan -  St. Jude Children's Research Hospital, Memphis, USA )
10 Dec 2019

CANDOR: Triple drug combo delays disease progression in stubborn multiple myeloma

Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA
CANDOR: Triple drug combo delays disease progression in stubborn multiple myeloma ( Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA )
10 Dec 2019

Daratumuab, carfilzomib and dexamethasone increases survival in patients with relapsed/refractory multiple myeloma

Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA
Daratumuab, carfilzomib and dexamethasone increases survival in patients with relapsed/refractory multiple myeloma ( Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA )
10 Dec 2019

Exploring the pathogenesis of AML and myelodysplastic syndromes using genome and transcriptome sequencing

Dr Ilaria Iacobucci - St. Jude Children's Research Hospital, Memphis, USA
Exploring the pathogenesis of AML and myelodysplastic syndromes using genome and transcriptome sequencing ( Dr Ilaria Iacobucci - St. Jude Children's Research Hospital, Memphis, USA )
10 Dec 2019

Multiple myeloma highlights from ASH 2019

Prof Heinz Ludwig - Wilhelmeninen Cancer Research Institute, Vienna, Austria
Multiple myeloma highlights from ASH 2019 ( Prof Heinz Ludwig - Wilhelmeninen Cancer Research Institute, Vienna, Austria )
10 Dec 2019

MURANO trial: Venetoclax-rituximab shows sustained benefit in relapsed/refractory chronic lymphocytic leukaemia

Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia
MURANO trial: Venetoclax-rituximab shows sustained benefit in relapsed/refractory chronic lymphocytic leukaemia ( Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia )
9 Dec 2019

Glasdegib in combination with azacitidine in patients with untreated higher-risk myelodysplastic syndromes and AML

Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA
Glasdegib in combination with azacitidine in patients with untreated higher-risk myelodysplastic syndromes and AML ( Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA )
9 Dec 2019